These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 33157099

  • 21. Sulforaphane improves outcomes and slows cerebral ischemic/reperfusion injury via inhibition of NLRP3 inflammasome activation in rats.
    Yu C, He Q, Zheng J, Li LY, Hou YH, Song FZ.
    Int Immunopharmacol; 2017 Apr; 45():74-78. PubMed ID: 28189971
    [Abstract] [Full Text] [Related]

  • 22. Pien-Tze-Huang, a Chinese patent formula, attenuates NLRP3 inflammasome-related neuroinflammation by enhancing autophagy via the AMPK/mTOR/ULK1 signaling pathway.
    Huang Z, Zhou X, Zhang X, Huang L, Sun Y, Cheng Z, Xu W, Li CG, Zheng Y, Huang M.
    Biomed Pharmacother; 2021 Sep; 141():111814. PubMed ID: 34146853
    [Abstract] [Full Text] [Related]

  • 23. Salidroside inhibits NLRP3 inflammasome activation and apoptosis in microglia induced by cerebral ischemia/reperfusion injury by inhibiting the TLR4/NF-κB signaling pathway.
    Liu J, Ma W, Zang CH, Wang GD, Zhang SJ, Wu HJ, Zhu KW, Xiang XL, Li CY, Liu KP, Guo JH, Li LY.
    Ann Transl Med; 2021 Nov; 9(22):1694. PubMed ID: 34988203
    [Abstract] [Full Text] [Related]

  • 24. Parkin-Dependent Mitophagy is Required for the Inhibition of ATF4 on NLRP3 Inflammasome Activation in Cerebral Ischemia-Reperfusion Injury in Rats.
    He Q, Li Z, Meng C, Wu J, Zhao Y, Zhao J.
    Cells; 2019 Aug 14; 8(8):. PubMed ID: 31416289
    [Abstract] [Full Text] [Related]

  • 25. Hypertonic saline mediates the NLRP3/IL-1β signaling axis in microglia to alleviate ischemic blood-brain barrier permeability by downregulating astrocyte-derived VEGF in rats.
    Wang QS, Ding HG, Chen SL, Liu XQ, Deng YY, Jiang WQ, Li Y, Huang LQ, Han YL, Wen MY, Wang MQ, Zeng HK.
    CNS Neurosci Ther; 2020 Oct 14; 26(10):1045-1057. PubMed ID: 32529750
    [Abstract] [Full Text] [Related]

  • 26. The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice.
    Franke M, Bieber M, Kraft P, Weber ANR, Stoll G, Schuhmann MK.
    Brain Behav Immun; 2021 Feb 14; 92():223-233. PubMed ID: 33307174
    [Abstract] [Full Text] [Related]

  • 27. Resveratrol alleviates cerebral ischemia/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction.
    He Q, Li Z, Wang Y, Hou Y, Li L, Zhao J.
    Int Immunopharmacol; 2017 Sep 14; 50():208-215. PubMed ID: 28683365
    [Abstract] [Full Text] [Related]

  • 28. PHLDA1 Blockade Alleviates Cerebral Ischemia/Reperfusion Injury by Affecting Microglial M1/M2 Polarization and NLRP3 Inflammasome Activation.
    Zhao H, Liu Y, Chen N, Yu H, Liu S, Qian M, Zhang Z.
    Neuroscience; 2022 Apr 01; 487():66-77. PubMed ID: 35093445
    [Abstract] [Full Text] [Related]

  • 29. Intranasal administration of β-1, 3-galactosyltransferase 2 confers neuroprotection against ischemic stroke by likely inhibiting oxidative stress and NLRP3 inflammasome activation.
    Guo X, Zhang Y, Liu C, Ren L, Gao S, Bi J, Liang J, Wang P.
    FASEB J; 2022 Oct 01; 36(10):e22542. PubMed ID: 36094000
    [Abstract] [Full Text] [Related]

  • 30. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice.
    Wang H, Zhong D, Chen H, Jin J, Liu Q, Li G.
    Life Sci; 2019 Jun 15; 227():101-113. PubMed ID: 31002919
    [Abstract] [Full Text] [Related]

  • 31. Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity.
    Peng J, Wang H, Gong Z, Li X, He L, Shen Q, Pan J, Peng Y.
    Mol Immunol; 2020 Jul 15; 123():74-87. PubMed ID: 32438202
    [Abstract] [Full Text] [Related]

  • 32. METTL14 regulates microglia/macrophage polarization and NLRP3 inflammasome activation after ischemic stroke by the KAT3B-STING axis.
    Li Y, Li J, Yu Q, Ji L, Peng B.
    Neurobiol Dis; 2023 Sep 15; 185():106253. PubMed ID: 37541353
    [Abstract] [Full Text] [Related]

  • 33. Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway.
    Hou B, Li D, Wang D, Jiang C, Wang G, Wang D, Yan G, Guo X, Zhao L, Wan Z, Fan C, Cao W, Ren H.
    Neuroscience; 2023 Aug 21; 526():74-84. PubMed ID: 37290685
    [Abstract] [Full Text] [Related]

  • 34. Progesterone Attenuates Stress-Induced NLRP3 Inflammasome Activation and Enhances Autophagy following Ischemic Brain Injury.
    Espinosa-Garcia C, Atif F, Yousuf S, Sayeed I, Neigh GN, Stein DG.
    Int J Mol Sci; 2020 May 26; 21(11):. PubMed ID: 32466385
    [Abstract] [Full Text] [Related]

  • 35. CX3CL1 inhibits NLRP3 inflammasome-induced microglial pyroptosis and improves neuronal function in mice with experimentally-induced ischemic stroke.
    Ge Y, Wang L, Wang C, Chen J, Dai M, Yao S, Lin Y.
    Life Sci; 2022 Jul 01; 300():120564. PubMed ID: 35461837
    [Abstract] [Full Text] [Related]

  • 36. Chronic cerebral hypoperfusion activates AIM2 and NLRP3 inflammasome.
    Matsuyama H, Shindo A, Shimada T, Yata K, Wakita H, Takahashi R, Tomimoto H.
    Brain Res; 2020 Jun 01; 1736():146779. PubMed ID: 32171704
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of perilipin 2 attenuates cerebral ischemia/reperfusion injury by blocking NLRP3 inflammasome activation both in vivo and in vitro.
    Liu XY, Li QS, Yang WH, Qiu Y, Zhang FF, Mei XH, Yuan QW, Sui RB.
    In Vitro Cell Dev Biol Anim; 2023 Mar 01; 59(3):204-213. PubMed ID: 37010675
    [Abstract] [Full Text] [Related]

  • 38. Forsythoside B alleviates cerebral ischemia-reperfusion injury via inhibiting NLRP3 inflammasome mediated by SIRT1 activation.
    Li Q, Zhang C, Sun X, Wang M, Zhang Z, Chen R, Sun X.
    PLoS One; 2024 Mar 01; 19(6):e0305541. PubMed ID: 38885233
    [Abstract] [Full Text] [Related]

  • 39. The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling.
    Qiu J, Wang M, Zhang J, Cai Q, Lu D, Li Y, Dong Y, Zhao T, Chen H.
    Int Immunopharmacol; 2016 Nov 01; 40():492-500. PubMed ID: 27769021
    [Abstract] [Full Text] [Related]

  • 40. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation.
    Ai QD, Chen C, Chu S, Zhang Z, Luo Y, Guan F, Lin M, Liu D, Wang S, Chen N.
    Transl Res; 2019 Oct 01; 212():36-53. PubMed ID: 31176667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.